Asia Pacific Drug Formulation & Bioavailability Congress September 05-07, 2016 Drug formulation-2016 welcomes Students, Pharmaceutical companies / industries, leading universities and research institutions, presenters, and exhibitors from all over the world to Beijing, China. We are delighted to invite you all to attend and register for the “Asia Pacific Drug Formulation & Bioavailability Congress” (Drug formulation -2016) which is going to be held during September 05-07, 2016 at Beijing, China. We invite you to join us at the Drug Formulation 2016, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Drug Formulation 2016 organizing committee look forward to meeting you in Beijing, China. Conference Highlights: • Preformulation & Formulation • Drug Formulation Procedures • Novel Drug Delivery System & Stability Studies • Drug Product Manufacturing • Analytical Method Development • Biopharmaceutics Classification System • Bioavailability Studies & Factors Affecting Bioavailability • Nutrient & Advances In Bioavailability • Medicinal Chemistry & Traditional Medicine • Clinical Studies & Contract Research Organizations • Regulatory & Quality Management Support • Entrepreneur Investment Special Benefits: • All accepted abstracts will be published in the respective Journal • Abstracts will receive a (DOI) provided by CrossRef • Special privileges on group registrations • Opportunity to organize Workshop/Symposia • Global Exposure to your Research • Best poster competition & young researcher competitions Organising Committee members: • Abdulmohsen H. Alrohaimi, Dean, School of Pharmacy, University in Shaqraa, Saudi Arabia. • Peng Li, Scientist in Medicine, University of California, Canada • Weiguo Dai, Scientific Director for Johnson &Johnson , USA • Sinerik Ayrapetyan, Professor in UNESCO, Armenia • Duc P. Do, Associate Professor at Chicago State University College of Pharmacy, USA • Ibrahim Al-Khars, President at AlAhsa Pharmacy Club, Saudi Pharmaceutical Society, Saudi Arabia • M. Fawzi Mahomoodally, Professor at University of Mauritius, Mauritius. Submit us your abstract in your area of your expertise, we are sure that your presentation will add a remarkable impact to the fellow researchers. Abstract submission, please kindly follow the link: http://drugformulation-bioavailability.pharmaceuticalconferences.com/abstract-submission.php

1. September 05-07, 2016
Beijing, China
Theme: Advanced Drug Formulation perspectives for Comprehensive
Bioavailability

2.  DoubleTree by Hilton Beijing
168 Guang An Men Wai Avenue,
Xi Cheng District
Beijing, China
 Conference Dates:
September,05-07, 2016

3.  Drug formulation-2016 welcomes Students, Pharmaceutical companies /
industries, leading universities and research institutions, presenters, and
exhibitors from all over the world to Beijing, China. We are delighted to invite
you all to attend and register for the “Asia Pacific Drug Formulation &
Bioavailability Congress” (Drug formulation -2016) which is going to be held
during September 05-07,2016 at Beijing, China. We invite you to join us at
the Drug Formulation 2016, where you will be sure to have a meaningful
experience with scholars from around the world. All members of the Drug
Formulation 2016 organizing committee look forward to meeting you in
Beijing, China.
 OMICS International Organizes 300+ Conferences Every Year across USA,
Europe & Asia with support from 1000 more scientific societies and Publishes
400+ Open access journals which contains over 30000 eminent
personalities, reputed scientists as editorial board members.

4. Why China?
China is currently the third largest pharmaceutical market in the world, posting $67
billion in revenue in 2011. With an anticipated compound growth rate of 24% between
2010 and 2020, China is expected to be the second largest market by 2015. Currently,
there are about 1,400 drug companies in China that are, collectively, able to produce
more than 60 dosage forms and about 5,000 different types of medicines. The current
Chinese market value of the dosage form medicines is worth about $50 B, accounting
for about 5.7% of the global market value. Internally, aiming to transform the Chinese
pharmaceutical industry, the Chinese government is encouraging the Chinese drug
companies to upgrade their manufacturing facility and improve their product quality. It
is therefore believed that the Chinese dosage form drug market will continue to grow
in a fast pace. It is expected to likely experience a CAGR of about 25% in the next five
years. Its market value could reach more than $158bn in 2016, and expand to 2023.

5.  The global generics sector reached $269.8 billion in 2012. This sector is
expected to reach $300.9 billion in 2013 and $518.5 billion in 2018,
with a compound annual growth rate (CAGR) of 11.5%.
 An overview of the global market for generic drug including coverage of
therapeutic
 Analyses of global market trends, with data from 2012, estimates for
2013, and projections of compound annual growth rates (CAGRs)
through 2018.The North American market is estimated to reach nearly
$73 billion in 2011 and is expected to increase at a 7.9% compound
annual growth rate to reach nearly $107 billion in 2016.
 The United States is currently spending almost $250 billion a year for
prescription drugs. If drugs were sold in a competitive market, without
government-imposed patent monopolies, this might achieve savings up
to $200 billion a year.

6. Preformulation & Formulation
Biopharmaceutics Classification
System
Drug Formulation Procedures
Bioavailability Studies & Factors
Affecting Bioavailability
Novel Drug Delivery System &
Stability Studies
Nutrient & Advances In
Bioavailability
Drug Product Manufacturing
Medicinal Chemistry &
Traditional Medicine
Analytical Method Development
Clinical Studies & Contract
Research Organizations

7. All accepted abstracts will be
published in respective OMICS
International Journals.
 Journal of Pharmaceutics & Drug Delivery
Research
 Drug Designing
 Journal of Developing Drugs
 Journal of Bioequivalence & Bioavailability
 Abstracts will be provided with Digital
Object Identifier by

8.  All accepted abstracts will be published in the
respective Journal
 Abstracts will receive a (DOI) provided by CrossRef
 Special privileges on group registrations
 Opportunity to organize Workshop/Symposia
 Global Exposure to your Research
 Best poster competition
 Young researcher competitions

9.  Abdulmohsen H. Alrohaimi, Dean, School of Pharmacy,
University in Shaqraa, Saudi Arabia.
 Peng Li, Scientist in Medicine, University of California, Canada
 Weiguo Dai, Scientific Director for Johnson &Johnson , USA
 Sinerik Ayrapetyan, Professor in UNESCO, Armenia
 Duc P. Do, Associate Professor at Chicago State University
College of Pharmacy, USA
 Ibrahim Al-Khars, President at AlAhsa Pharmacy Club, Saudi
Pharmaceutical Society, Saudi Arabia
 M. Fawzi Mahomoodally, Professor at University of Mauritius,
Mauritius.

10. Why to attend Drug Formulation 2016?
 Best platform to develop new partnership & collaborations.
 Best location to speed up your route into every territory in the
World.
 89% our conference attendees are the Key contact in their
labs purchasing decisions.
 Our exhibitor booths were visited 4-5 times by 80% of the
attendees during the conference.
 Past exhibitor’s feedback reveals ample of enquiries
perceived from the conference attendees.
 Network development with both Academia and Business.

11.  Join Our Mailing List
 Suggest A Speaker
 Suggestions
 Invite Proposals